| Literature DB >> 35879184 |
I Leoz Gordillo1, J García Remiro2, C Barbero Peco2, A Alonso Pérez3, A García Salido2, A González Brabin2, M Cabrero Hernández2, M Nieto Moro2.
Abstract
Entities:
Mesh:
Year: 2022 PMID: 35879184 PMCID: PMC9250885 DOI: 10.1016/j.medine.2022.06.018
Source DB: PubMed Journal: Med Intensiva (Engl Ed) ISSN: 2173-5727
Clinical characteristics of patients admitted to the PICU.
| Overall patients (N = 93) | Non-COVID (N = 62) | COVID (N = 31) | ||
|---|---|---|---|---|
| Age (years), median (IQR) | 9.54 (9) | 8.67 (10.8) | 9.61 (3.8) | .2 |
| Sex (men), n (%) | 55 (59%) | 37 (60%) | 18 (58%) | 1 |
| Underlying disease, n (%) | 9 (9.6%) | 7 (11%) | 2 (6.5%) | .46 |
| Inotropic support, n (%) | 29 (31%) | 12 (19%) | 17 (55%) | |
| Invasive mechanical ventilation, n (%) | 16 (17%) | 14 (23%) | 2 (6.5%) | .079 |
| ICU stay (days), median (IQR) | 6 (7.5) | 7 (10) | 5 (4) | .22 |
| Hospital stay (days), median (IQR) | 11 (12) | 12.5 (19) | 10 (4) | .41 |
In bold, statistically significant values.
Comparative analysis of clinical-evolutionary data of patients who went to medical visits after PICU admission.
| Overall patients (N = 93) | Non-COVID (N = 62) | COVID (N = 31) | ||
|---|---|---|---|---|
| Follow-up by specialists, n (%) | 83 (89%) | 55 (89%) | 28 (90%) | 1 |
| New for pharmacological treatment, n (%) | 31 (33%) | 23 (37%) | 9 (29%) | .494 |
| Generalized weakness, n (%) | 22 (24%) | 9 (15%) | 13 (42%) | |
| FSS scale, median score (IQR) | 6 (0) | 6 (0) | 6(0) | .062 |
| PCPC scale, median score (IQR) | 1 (0) | 1 (0) | 1 (0) | .2 |
| Psychological damage, n (%) | 41 (44%) | 29 (47%) | 12/31 (39%) | .46 |
| Reduced Zarit scale, median score (IQR) | 12 (7.2) | 12 (8) | 11 (7) | .74 |
| Co-sleeping after admission, n/total (%) | 14/80 (18%) | 10/55 (18%) | 4/25 (16%) | 1 |
| Did not go to school when medical visit took place, n (%) | 38 (41%) | 30 (48%) | 8 (26%) | |
| Patient quality of life scale, median score (IQR) | 82.9 (14.7) | 82.5 (14.5) | 83.4 (10.1) | .37 |
| Family quality of life scale, median score (IQR) | 75.6 (21.1) | 77 (17.8) | 75 (24.4) | .82 |
| Post-PICU syndrome in the patient, n/total (%) | 25/79 (32%) | 15/50 (30%) | 10/29 (34%) | .62 |
| Post-PICU follow-up medical visit, n/total (%) | 39 (42%) | 25 (40%) | 14 (45%) | .66 |
In bold, statistically significant values.